Mercia Asset Management : Synthetic genes company raises £7.8m after new contract wins
Camena Bioscience, a Cambridge-based company which provides synthetic genes to the pharmaceutical and biotechnology industries, has completed a £7.8m Series A funding round led by Mercia...
Source: marketscreener.com